93 related articles for article (PubMed ID: 17611027)
1. Changes in opioid receptor proteins during mitochondrial impairment in differentiated SK-N-SH cells.
Raut A; Rao VR; Ratka A
Neurosci Lett; 2007 Jul; 422(3):187-92. PubMed ID: 17611027
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of impaired mitochondrial energy production on the function of mu and delta opioid receptors in neuronal SK-N-SH cells.
Raut A; Iglewski M; Ratka A
Neurosci Lett; 2006 Aug; 404(1-2):242-6. PubMed ID: 16808998
[TBL] [Abstract][Full Text] [Related]
3. Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.
Kivell BM; Day DJ; McDonald FJ; Miller JH
Brain Res Dev Brain Res; 2004 Mar; 149(1):9-19. PubMed ID: 15013624
[TBL] [Abstract][Full Text] [Related]
4. Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals.
Stevens CW; Brasel CM; Mohan S
Neurosci Lett; 2007 Jun; 419(3):189-94. PubMed ID: 17452077
[TBL] [Abstract][Full Text] [Related]
5. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells.
Wang J; Green PS; Simpkins JW
J Neurochem; 2001 May; 77(3):804-11. PubMed ID: 11331409
[TBL] [Abstract][Full Text] [Related]
6. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
7. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain.
Pol O; Murtra P; Caracuel L; Valverde O; Puig MM; Maldonado R
Neuropharmacology; 2006 Jan; 50(1):123-32. PubMed ID: 16360182
[TBL] [Abstract][Full Text] [Related]
8. Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.
Jiménez N; Puig MM; Pol O
J Pharmacol Exp Ther; 2006 Jan; 316(1):261-70. PubMed ID: 16183704
[TBL] [Abstract][Full Text] [Related]
9. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
10. Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia.
Rau KK; Caudle RM; Cooper BY; Johnson RD
J Chem Neuroanat; 2005 Jun; 29(4):255-64. PubMed ID: 15927787
[TBL] [Abstract][Full Text] [Related]
11. Engineering and functional immobilization of opioid receptors.
Ott D; Neldner Y; Cèbe R; Dodevski I; Plückthun A
Protein Eng Des Sel; 2005 Mar; 18(3):153-60. PubMed ID: 15790572
[TBL] [Abstract][Full Text] [Related]
12. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
[TBL] [Abstract][Full Text] [Related]
13. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation.
Chakrabarti S; Yang W; Law PY; Loh HH
Mol Pharmacol; 1997 Jul; 52(1):105-13. PubMed ID: 9224819
[TBL] [Abstract][Full Text] [Related]
14. Opioid μ-receptors as new target for insulin resistance.
Cheng KC; Asakawa A; Li YX; Liu IM; Amitani H; Cheng JT; Inui A
Pharmacol Ther; 2013 Sep; 139(3):334-40. PubMed ID: 23688574
[TBL] [Abstract][Full Text] [Related]
15. NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Israel Y; Kandov Y; Khaimova E; Kest A; Lewis SR; Pasternak GW; Pan YX; Rossi GC; Bodnar RJ
Peptides; 2005 Jul; 26(7):1167-75. PubMed ID: 15949635
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of proanthocyanidin against oxidative ovarian damage induced by 3-nitropropionic acid in mice.
Zhang JQ; Xing BS; Zhu CC; Shen M; Yu FX; Liu HL
Genet Mol Res; 2015 Mar; 14(1):2484-94. PubMed ID: 25867394
[TBL] [Abstract][Full Text] [Related]
17. Morphine sulfate concomitantly decreases neuronal differentiation and opioid receptor expression in mouse embryonic stem cells.
Dholakiya SL; Aliberti A; Barile FA
Toxicol Lett; 2016 Apr; 247():45-55. PubMed ID: 26877219
[TBL] [Abstract][Full Text] [Related]
18. Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
Selley DE; Bidlack JM
J Pharmacol Exp Ther; 1992 Oct; 263(1):99-104. PubMed ID: 1328614
[TBL] [Abstract][Full Text] [Related]
19. Chronic exposure to morphine decreases the expression of EAAT3 via opioid receptors in hippocampal neurons.
Guo M; Cao D; Zhu S; Fu G; Wu Q; Liang J; Cao M
Brain Res; 2015 Dec; 1628(Pt A):40-9. PubMed ID: 25839761
[TBL] [Abstract][Full Text] [Related]
20. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.
Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
